期刊文献+

根除幽门螺杆菌三联疗法临床观察 被引量:3

The clinical study on the triple therapy for the eradication of Helicobacter pylori infection
暂未订购
导出
摘要 目的 观察以质子泵抑制剂 (PPI)、克拉霉素为中心的三联疗法治疗幽门螺杆菌 (HP)阳性十二指肠溃疡的疗效 ,比较甲硝唑和痢特灵的疗效及副作用 ,筛选理想的三联疗法。方法 胃镜确诊十二指肠溃疡并经病理组织学及 14 C-尿素呼吸试验证实 HP感染者 184例 ,随机分成 2组 ,A组用洛塞克、克拉霉素及甲硝唑 ,B组用洛塞克、克拉霉素及痢特灵 ,每日 2次 ,连续 7d,停药 4周后复查胃镜观察溃疡愈合程度 ,同时经 14 C-尿素呼吸试验及胃镜证实 HP根除情况。结果 溃疡总愈合率 :A组 91.4 % (85 / 93) ,B组 93.4 % (85 / 91) ,2种疗法比较差异无显著意义 (P >0 .0 5 ) ;HP根除率 :A组 90 .3% (84 / 93) ,B组 93.4 % (85 / 91) ,2种疗法比较差异无显著意义 (P >0 .0 5 ) ;轻度不良反应 :A组 16 .1% (15 / 93) ,B组 4 .4 % (4/ 91) ,B组反应明显轻于 A组 (P <0 .0 5 )。结论  2组三联疗法根除 HP及治疗十二指肠溃疡均有良好疗效 ;痢特灵具有抗 HP作用强、无耐药性、价格低廉、副作用少等优点 ,可替代甲硝唑配伍于洛塞克、克拉霉素的三联疗法中 ,是一种理想的适合国情的根除 Objective In order to observe the efficacies on eradicating Helicobacter pylori(HP) and healing duodenal ulcer(DU), and to choose ideal triple therapeutic regimen that mainly include omeprazole and clarithromycin,and metronidazole.Methods 184 patients with DU were infected by HP diagnosed by gastroscope,histology and 14C urea breath test. All patients were allocated randomly into group A and group B.Group A:omeprazole 20 mg bid, clarithromycin 250 mg bid and metronidazole 400 mg bid; Group B:omeprazole 20 mg bid, clarithromycin 250 mg bid and furanzolidone 100 mg bid.The course of therapy were 7 days. After 4 weeks of discontinuing these pills, the results of HP eradication, status of ulcer healing and side effects were checked and recorded.Results The total rates of ulcer healing in group A was 91.4%, in group B was 92.3%. The HP eradication rate in group A and B were 90.3% and 93.4% respectively.The differences between the two regimens weren't significant(P>0.05).Significant differences in mild side effects were observed (P<0.05) which were 16.1% and 4.4% in group A and group B,respectively.Conclusions Two groups that include PPI triple therapeutic regimens can effectively eradicate HP and heal DU.Furanzolidone possesses the advantages of good efficacy,no resistance,cheap and mild side effects.So it could replace metronidazole to be used in the triple therapeutic regimens along with omeprazole and clarithromycin.It is suitable to the native condition.
出处 《中国地方病学杂志》 CAS CSCD 北大核心 2003年第5期450-452,共3页 Chinese Jouranl of Endemiology
关键词 幽门螺杆菌 三联疗法 质子泵抑制剂 克拉霉素 十二指肠溃疡 metronidazole furanzolidone triple therapeutic regiments Helicobacter pylori duodenal ulcer
  • 相关文献

参考文献10

  • 1胡品津 李榆元 等.首届太平洋幽门螺杆菌国际会议纪要[J].中华消化杂志,1996,16(3):160-160.
  • 2李瑜元.克拉霉素三联疗法治疗幽门螺杆菌阳性十二指肠溃疡[J].现代消化及介入诊疗,2000,5(1):31-33. 被引量:2
  • 3刘文忠,吕宝妹,萧树东,徐蔚文,施尧,张德中.含克拉霉素的短程三联疗法根除幽门螺杆菌[J].中华内科杂志,1996,35(12):803-806. 被引量:42
  • 4戴宁,钱可大,唐训球.幽门螺杆菌对抗菌药物的耐药性[J].中华消化杂志,1998,18(1):48-49. 被引量:32
  • 5杨艺 王振宇 林兆鑫 等.幽门螺杆菌感染的治疗[J].消化病诊断和治疗,2002,2(5):95-201.
  • 6胡品津,萧树东,张万岱,胡伏莲.第三次全国幽门螺杆菌学术会议纪要[J].中华消化杂志,2002,22(12):743-744. 被引量:18
  • 7胡伏莲 杨桂彬 崔梅花 胡伏莲 周殿元.根除HP感染的治疗方案[A].胡伏莲,周殿元.HP感染的基础与临床:修订版[C].北京:中国科学技术出版社,2002.338—346.
  • 8Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment [J]. Eur J Gastroenterol Hepatol, 1995,7 : 1-3.
  • 9Lind T, Veldhuyzen V, Zanten S, et al. Eradication of Helicohater pylori using one-week triple therapy combining omeprazole with two antimicrobials:the Mach 1 study[J]. Helicobacter, 1996,1 : 138-144.
  • 10Xiao SD,Liu WZ, Shi Y. Furazolidone-containing shortterm triple therapies are effective in the treatment of helicobacter pylori infective [J]. Aliment Pharmacol Ther, 1999,13 : 317-322.

二级参考文献6

  • 1萧树东,中华消化杂志,1995年,15卷,增刊,16页
  • 2萧树东,Hepatogastroenterology,1990年,37卷,503页
  • 3张曼林,临床内科杂志,1997年,14卷,52页
  • 4史碧山,中华消化内镜杂志,1997年,14卷,26页
  • 5Xia H X,Gut,1995年,37卷,增1期,55页
  • 6Xia H,Antimicrob Agents Chemother,1994年,38卷,2357页

共引文献93

同被引文献25

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部